Chemistry:Pelubiprofen
From HandWiki
Short description: Chemical compound
 | |
| Clinical data | |
|---|---|
| Trade names | Pelubi |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| UNII | |
| Chemical and physical data | |
| Formula | C16H18O3 |
| Molar mass | 258.317 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Pelubiprofen is a nonsteroidal anti-inflammatory drug of the profen class used to treat back pain and osteoarthritis.[1]
Pelubiprofen was developed in South Korea by Daewon Pharmaceuticals and it is marketed in Korea and Russia,[2] among other countries.
Research
Pelubiprofen is being studied for use in combination with eperisone.[3]
Because pelubiprofen has low water solubility, development of salt formulations with better solubility are being studied.[4]
References
- ↑ "Pelubiprofen". AdisInsight. https://adisinsight.springer.com/drugs/800000947.
- ↑ "Daewon Pharm wins $3 million deal to export Pelubi to Indonesia". Korea Biomedial Review. September 26, 2023. https://www.koreabiomed.com/news/articleView.html?idxno=22165.
- ↑ "(Eperisone + pelubiprofen) by Daewon Pharmaceutical for Low Back Pain: Likelihood of Approval". 5 June 2023. https://www.pharmaceutical-technology.com/data-insights/eperisone-pelubiprofen-daewon-pharmaceutical-low-back-pain-likelihood-of-approval.
- ↑ Park, Ji Yeon; Oh, Dong Ho; Park, Sang-Wook; Chae, Bo Ram; Kim, Chul Woo; Han, Sang Heon; Shin, Hyeon Jong; Yeom, Soo Bin et al. (2021). "Development of Pelubiprofen Tromethamine with Improved Gastrointestinal Safety and Absorption". Pharmaceutics 13 (5): 745. doi:10.3390/pharmaceutics13050745. PMID 34070062.
 |  |
